v3.22.2.2
Revenue from Contracts with Customers
9 Months Ended
Sep. 30, 2022
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 1 to our consolidated financial statements in Item 8 of the 2021 Annual Report on Form 10-K.

Disaggregation of Revenue

Our revenue is disaggregated based on reporting segment, product category and geographical region. We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (“OEM”). Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following tables present revenue from contracts with customers by reporting segment, product category and geographical region for the three and nine-month periods ended September 30, 2022 and 2021 (in thousands):

Three Months Ended

Three Months Ended

September 30, 2022

September 30, 2021

    

United States

    

International

    

Total

    

United States

    

International

    

Total

Cardiovascular

 

  

 

 

  

 

  

 

  

 

  

Peripheral Intervention

$

67,200

$

43,498

$

110,698

$

61,282

$

39,777

$

101,059

Cardiac Intervention

 

33,194

53,654

 

86,848

 

30,562

 

49,251

 

79,813

Custom Procedural Solutions

 

27,078

18,614

 

45,692

 

27,895

 

21,540

 

49,435

OEM

 

29,425

6,286

 

35,711

 

25,025

 

4,372

 

29,397

Total

 

156,897

122,052

 

278,949

 

144,764

 

114,940

 

259,704

 

Endoscopy

Endoscopy Devices

 

7,674

 

552

 

8,226

 

6,741

 

576

 

7,317

Total

$

164,571

$

122,604

$

287,175

$

151,505

$

115,516

$

267,021

Nine Months Ended

Nine Months Ended

September 30, 2022

September 30, 2021

   

United States

   

International

   

Total

   

United States

   

International

   

Total

Cardiovascular

 

 

 

  

 

  

 

  

 

  

Peripheral Intervention

$

195,095

$

132,331

$

327,426

$

181,383

$

118,190

$

299,573

Cardiac Intervention

 

95,652

162,257

 

257,909

 

93,030

 

147,173

 

240,203

Custom Procedural Solutions

 

80,951

60,096

 

141,047

 

80,179

 

63,313

 

143,492

OEM

 

87,269

18,904

 

106,173

 

75,335

 

14,399

 

89,734

Total

 

458,967

373,588

 

832,555

 

429,927

 

343,075

 

773,002

 

Endoscopy

Endoscopy Devices

 

23,270

 

1,741

 

25,011

 

21,721

 

1,536

 

23,257

Total

$

482,237

$

375,329

$

857,566

$

451,648

$

344,611

$

796,259